Menu

Blog

Mar 3, 2022

Peter Diamandis Describes How Applying AI to Drug Discovery is Causing Positive Disruption to Biopharma

Posted by in categories: biotech/medical, Peter Diamandis, robotics/AI

The content of Peter’s email blast has been edited by me (can’t help myself). But I believe I have captured its essence and hope you enjoy the retelling. As always your comments are welcomed.

What is Insilico Medicine?

Insilico Medicine is a pioneering drug company that is powered by a “drug discovery engine” that sifts through millions of data samples to determine the signature biological characteristics of specific diseases. It then identifies the most promising treatment targets and uses a new AI technique called generative adversarial networks (GANs) to create molecules perfectly suited against them.

Leave a reply